GlassScriptPhysician profile
Debra Banks
NPI 1275755167
$3,648.97
in general payments reported to CMS, 2019-2025
18 companies · $810 in 2025
The $810 reported for 2025 was more than what 83% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $287 · 2022: $1,079 · 2023: $592 · 2024: $882 · 2025: $810.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,284.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,283.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merz North America, INC. | $974.39 | 2021-2023 | Xeomin |
| Abbvie INC. | $862.99 | 2023-2025 | |
| Allergan, INC. | $305.43 | 2021-2022 | |
| Galderma Laboratories, L.P. | $295.77 | 2021-2025 | Nemluvio |
| Janssen Biotech, INC. | $260.53 | 2023-2025 | Tremfya |
| Amgen INC. | $219.55 | 2023-2025 | Otezla, Otezla |
| Genzyme Corporation | $186.26 | 2025 | |
| Sun Pharmaceutical Industries INC. | $92.40 | 2023-2024 | Odomzo, Blu-U |
| Regeneron Healthcare Solutions, INC. | $77.13 | 2024-2025 | Libtayo, Dupixent |
| E.R. Squibb & Sons, L.L.C. | $76.41 | 2024-2025 | Sotyktu |
| Incyte Corporation | $63.30 | 2023-2024 | Opzelura |
| Novartis Pharmaceuticals Corporation | $53.54 | 2023-2025 | |
| Lilly USA, LLC | $39.21 | 2023 | Taltz |
| Medtronic, INC. | $39.11 | 2024-2025 | Venaseal |
| Convatec INC. | $39.05 | 2023 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Leo Pharma INC. | $23.58 | 2023 | Adbry |
| Verrica Pharmaceuticals INC. | $22.82 | 2023 | Ycanth |
| Arcutis Biotherapeutics, INC. | $17.50 | 2025 | Zoryve |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Debra Banks listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.